Burning Rock Biotech Limited Announces Results of 2025 Annual General Meeting

Burning Rock Biotech Limited held its 2025 Annual General Meeting on December 23, 2025, where all proposed shareholder resolutions were passed. Key resolutions included the ratification of Ernst & Young Hua Ming LLP as the company's auditor for the fiscal year ending December 31, 2025, with directors authorized to set their remuneration. Additionally, Feng Deng and Licen Lisa Xu were re-elected as directors. The shareholders also authorized the directors to take necessary actions to effect these resolutions. Burning Rock Biotech Limited is focused on applying next-generation sequencing (NGS) technology in precision oncology, covering therapy selection testing for late-stage cancer patients and early cancer detection.